What Niagen Bioscience, Inc. does.

Unless otherwise indicated or the context otherwise requires, references to the Company, Niagen Bioscience, we, us and our refer to Niagen Bioscience, Inc. and its consolidated subsidiaries.

On May 21, 2008, Cody Resources, Inc., a Nevada corporation and a public company, (Cody) entered into an Agreement and Plan of Merger (Merger Agreement), by and among Cody, CDI Acquisition, Inc., a California corporation and wholly-owned subsidiary of Cody (Acquisition Sub), and ChromaDex, Inc. (Merger). Subsequent to the signing of the Merger Agreement, Cody merged with and into a Delaware corporation. On June 20, 2008, Cody amended its articles of incorporation to change its name to ChromaDex Corporation. On April 25, 2016, ChromaDex Corporation became listed on the Nasdaq Capital Market (Nasdaq).

On March 12, 2017, ChromaDex Corporation acquired Healthspan Research LLC, a consumer product company offering Tru Niagen® branded products. This marked the strategic shift to become a global bioscience company dedicated to healthy aging. On January 15, 2021, Healthspan Research LLC was dissolved. Prior to its dissolution, Healthspan Research, LLC contributed its assets and liabilities to ChromaDex, Inc., a wholly owned subsidiary of ChromaDex Corporation,

Revenue and profit, by fiscal year.

More on NAGE.

• Niagen Bioscience, Inc. summary
• Niagen Bioscience, Inc. financial statements
• Niagen Bioscience, Inc. key metrics
• Niagen Bioscience, Inc. health scores and style box
• Niagen Bioscience, Inc. earnings
• Niagen Bioscience, Inc. dividends
• Niagen Bioscience, Inc. valuation
• Niagen Bioscience, Inc. ownership and insiders
• Niagen Bioscience, Inc. peers

Figures from Niagen Bioscience, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.